You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Coagulation Disorders

Citations 1-10 of 13 total displayed.

Most recent content (23 Apr 2008):

Medical News & Perspectives
Guidelines for von Willebrand Disease Urge Routine Screening for Bleeding
Mike Mitka
JAMA 2008; 299: 1890. [Extract] [Full text] [PDF]  

Past content (since Mar 1999):

Letters
Timing of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes—Reply
Gregg W. Stone; for the ACUITY Investigators
JAMA 2007; 298: 37-a-38-a. [Extract] [Full text] [PDF]  

Letters
Timing of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes
Harris V. K. Naina; Samar Harris; Atul Singla
JAMA 2007; 298: 37. [Extract] [Full text] [PDF]  

Letters
Fixed-Dose Unfractionated Heparin vs Low-Molecular-Weight Heparin for Venous Thromboembolism
Huichun Zhan; Haoyi Zheng
JAMA 2007; 297: 261-a-262-a. [Extract] [Full text] [PDF]  

Letters
Fixed-Dose Unfractionated Heparin vs Low-Molecular-Weight Heparin for Venous Thromboembolism
Neeraj Bhala; Ashit Shah; Andrew King; Chakri Molugu
JAMA 2007; 297: 261. [Extract] [Full text] [PDF]  

Letters
Fixed-Dose Unfractionated Heparin vs Low-Molecular-Weight Heparin for Venous Thromboembolism
Darrell W. Harrington; Ayad Jindeel
JAMA 2007; 297: 262-a. [Extract] [Full text] [PDF]  

Letters
Fixed-Dose Unfractionated Heparin vs Low-Molecular-Weight Heparin for Venous Thromboembolism
Jonathan Lee Edwards
JAMA 2007; 297: 262. [Extract] [Full text] [PDF]  

Letters
Fixed-Dose Unfractionated Heparin vs Low-Molecular-Weight Heparin for Venous Thromboembolism—Reply
Clive Kearon; Jeffrey S. Ginsberg; Jim A. Julian; Michael Gent; for the Fixed-Dose Heparin (FIDO) Investigators
JAMA 2007; 297: 263. [Extract] [Full text] [PDF]  

Original Contributions
Thromboembolic Adverse Events After Use of Recombinant Human Coagulation Factor VIIa
Kathryn A. O’Connell; Jennifer J. Wood; Robert P. Wise; Jay N. Lozier; M. Miles Braun
JAMA 2006; 295: 293-298. [Abstract] [Full text] [PDF]  

Research Letters
Ribavirin and Use of Clotting Factors in Patients With Hemophilia and Chronic Hepatitis C
Takashi Honda; Hidenori Toyoda; Kazuhiko Hayashi; Yoshiaki Katano; Motoyoshi Yano; Isao Nakano; Kentaro Yoshioka; Hidemi Goto; Koji Yamamoto; Junki Takamatsu
JAMA 2005; 293: 1190-b-1192-b. [Extract] [Full text] [PDF]  

[Next page]
Pages: 1 2

 Collections
 •Sign up for Topic Collection Alerts
 •Topic Collections Home
 • Show Coagulation Disorders
 collections from JAMA & Archives Journals.
 •Related collections:
  •Hematology/ Hematologic Malignancies
  •Anemias
  •Coagulation Disorders
  •Leukemias/ Lymphomas
  •Hematology, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.